Biotech Bear Market: After The Bubble Burst…

Biotech stocks are “bobbing” just above the early October bottom with a bit of buying support but still 13% off mid-September highs. Sentiment remains negative because of long term pricing concerns.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.